Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

1,897.01
+3.530.19%
Number of Gainers:6
Number of Losers:4
Number of Flat:1
PE:- -
High:1,922.15
Open:1,893.50
Low:1,893.50
Close:1,893.48
Volume:13.97M
Turnover:928.54M
Market Cap:209.79B
Float Cap:209.28B

Loading ...

U.S. Stocks to Watch: Tesla, Jefferies, Apollo, Gilead, Estée Lauder, and More

Dow Jones
·
Mar 24

Viatris Inc. : Barclays Raises Target Price to $17 From $15

THOMSON REUTERS
·
Mar 24

Viatris price target raised to $17 from $15 at Barclays

TIPRANKS
·
Mar 24

Deals of the day-Mergers and acquisitions

Reuters
·
Mar 24

Analysts Are Bullish on Top Healthcare Stocks: Siemens Healthineers AG (SEMHF), Viatris (VTRS)

TIPRANKS
·
Mar 24

PRESS DIGEST -Wall Street Journal - March 24

Reuters
·
Mar 24

Galapagos and Gilead discuss OM336 collaboration with 20%-23% royalties

Reuters
·
Mar 24

Gilead to acquire Ouro Medicines for $1.675B

TIPRANKS
·
Mar 24

Gilead - Currently in Advanced Talks With Galapagos With Respect to Potential Research and Development Collaboration on Acquired Ouro Medicines Assets

THOMSON REUTERS
·
Mar 24

Gilead: Ouro Medicines to GET up to $500 Mln in Contingent Milestone Payments

THOMSON REUTERS
·
Mar 24

Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases

THOMSON REUTERS
·
Mar 24

Gilead: Will Acquire All of Outstanding Equity of Ouro Medicines for a Total of $1,675 Mln in Upfront Cash Consideration

THOMSON REUTERS
·
Mar 24

Gilead: Would Retain Sole Worldwide Commercialization Rights Other Than in Greater China, Co Would Pay Galapagos Royalties of 20%-23% of Net Sales

THOMSON REUTERS
·
Mar 24

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 24

BRIEF-Tonix Pharmaceuticals Announces Presentations At World Vaccine Congress Washington 2026

Reuters
·
Mar 24

GeoVax Labs Inc expected to post a loss of $6.17 a share - Earnings Preview

Reuters
·
Mar 24

Inovio reports pDFVIII DNA therapy corrects bleeding in hemophilia A mice

Reuters
·
Mar 24

Gilead Sciences Nears Acquisition of Ouro Medicines for Up to $2 Billion, Financial Times Says

MT Newswires Live
·
Mar 24

BRIEF-Gilead Nears Up To $2 Billion Deal For Autoimmune Biotech Ouro Medicines - FT

Reuters
·
Mar 24

Gilead Nears up to $2Bn Deal for Autoimmune Biotech Ouro Medicines - FT

THOMSON REUTERS
·
Mar 24